Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Adrenocortical Carcinoma Treatment Companies

Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that arises in the adrenal cortex. Pharmaceutical companies develop and manufacture medications for the treatment of adrenocortical carcinoma. Companies involved in addressing adrenocortical carcinoma contribute to diagnostics, treatment, research, and support services.

Latest Adrenocortical Carcinoma Treatment Companies Updates:

Jan 2024

PharmaMar (Spain) Presented positive Phase 2 data demonstrating the efficacy and safety of their novel oral drug, lurbinectedin, in treating advanced ACC.Initiated Phase 3 clinical trials evaluating lurbinectedin in combination with other therapies for patients with unresectable ACC.

Eisai Co.,Received FDA Fast Track designation for their oral small molecule drug, lenvatinib, for treating inoperable ACC patients with specific genetic mutations.Partnered with leading cancer centers to conduct clinical trials investigating lenvatinib in combination with immunotherapy for treating ACC.

Shanghai Jiao Tong University School of Medicine (China) Conducted preclinical research identifying potential new therapeutic targets for ACC treatment based on gene expression analysis.Collaborated with international research teams to accelerate the development of novel therapies for ACC.

The Adrenocortical Carcinoma Foundation (ACF) (US) Launched a new patient-centered clinical trial registry specifically focused on ACC research and treatment advancements.Advocated for increased funding for ACC research and improved access to clinical trials for ACC patients.

National Cancer Institute (NCI) (US) Funded new research projects investigating the use of immunotherapy and targeted therapies in combination for treating ACC patients with specific genetic variants.Continued supporting clinical trials and collaborative research efforts aimed at improving ACC treatment outcomes.

List of Adrenocortical Carcinoma Treatment Key companies in the market

Arqule, Pfizer Ltd.

EnGeneIC Ltd

Exelixis, Inc.

Millendo Therapeutics, Inc.

Merck & Co.

Orphagen Pharmaceuticals, Inc.

HRA Pharma

Bristol-Myers Squibb Company

General Electric Company

WG Critical Care

Mylan N.V.

Adrenocortical Carcinoma Treatment Market Highlights:

Adrenocortical Carcinoma Treatment Market Size

Adrenocortical Carcinoma Treatment Market Trends

Adrenocortical Carcinoma Treatment Market Analysis

Adrenocortical Carcinoma Treatment Market Share

Adrenocortical Carcinoma Treatment Market Highlights:

Adrenocortical Carcinoma Treatment Market Trends

Adrenocortical Carcinoma Treatment Market Analysis

Adrenocortical Carcinoma Treatment Market Share

Adrenocortical Carcinoma Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.